ONKOSXCEL THERAPEUTICS - Trademark Details
Status: 630 - New Application - Record Initialized Not Assigned To Examiner
Serial Number
97319590
Word Mark
ONKOSXCEL THERAPEUTICS
Status
630 - New Application - Record Initialized Not Assigned To Examiner
Status Date
2022-03-22
Filing Date
2022-03-18
Mark Drawing
4000 - Standard character mark
Typeset
Attorney Name
Statements
Goods and Services
Pharmaceuticals; pharmaceutical preparations: biopharmaceuticals; biopharmaceutical preparations: pharmaceuticals and biopharmaceuticals for the treatment of oncology; pharmaceuticals and biopharmaceuticals for the treatment of immuno-oncology; pharmaceuticals and biopharmaceuticals for the treatment of cancer, tumor, prostate cancer, castration resistant prostate cancer, neuro endocrine tumors, small cell neuroendocrine cancer, small cell lung cancer, adenocarcinoma, melanoma, sarcoma, soft tissue sarcoma, acute myeloid leukemia, head and neck cancers, pancreatic cancer, neuroendocrine prostate cancer
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2022-03-22
Primary Code
005
Current Trademark Owners
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Correspondences
Name
PERRY J. VISCOUNTY
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2022-03-22 | NEW APPLICATION ENTERED IN TRAM |